8-K current report · filed Oct 27, 2026

Ecolab (ECL) 8-K Current Report: October 27, 2026

Item EX-99.1Item EX-99.2Item 2.02ECL overview

Short answer

Ecolab (ECL) filed an 8-K current report with the SEC on October 27, 2026 reporting Item EX-99.1 (Exhibit EX-99.1), Item EX-99.2 (Exhibit EX-99.2), Item 2.02 (Results of Operations and Financial Condition). Ecolab announced third-quarter 2026 earnings for the period ended September 30, 2026.

Ecolab 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Ecolab announced third-quarter 2026 earnings for the period ended September 30, 2026
  • News release and supplemental data available in Exhibits 99.1 and 99.2
  • Supplemental materials support the conference call discussing quarterly results
  • Restructuring plan referenced as a forward-looking initiative, with execution and regulatory risks for investors

Item EX-99.1 · Exhibit EX-99.1

  • Q3 sales $4.695B, up 13%, with organic growth accelerating to 7%, signaling broad-based demand and pricing strength
  • Adjusted EPS $2.18, up 5%, despite an approximate 10% CoolIT-related amortization and financing headwind
  • Organic operating margin 19.6%, up 70 bps, as 5% pricing and productivity offset commodity inflation
  • 2026 adjusted EPS outlook $8.10 to $8.20, up 8% to 9%, maintaining guidance despite acquisition-related costs
  • Global High-Tech organic sales surged 63%, while Ovivo Electronics and CoolIT are expected to add approximately 2 percentage points to annual organic growth

Item EX-99.2 · Exhibit EX-99.2

  • 3Q 2026 sales $4.695B, up 13%, with organic growth accelerating to 7% on 2% volume and 5% pricing
  • Adjusted EPS $2.18, up 5%, despite an approximate 10-point CoolIT amortization and financing headwind
  • Organic operating margin 19.6%, up 70 bps, supporting management’s 20% adjusted margin target for 2027
  • Growth concentrated in High-Tech, 63% organic, and Life Sciences, 17%, reinforcing AI infrastructure and bioprocessing exposure
  • Full-year adjusted EPS guidance $8.10 to $8.20, up 8% to 9%, while net debt/adjusted EBITDA increased to 2.9 from 1.6

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Ecolab 8-K filings

Get the next ECL 8-K as it lands

Follow ECL for push alerts, or ask the research agent what this filing means.